Comparison of Contrast-Enhanced CT and [(18)F]FDG PET/CT Analysis Using Kurtosis and Skewness in Patients with Primary Colorectal Cancer.
Publisher DOI
PubMed ID
28224325
Abstract
PURPOSE
Heterogeneity is a key feature of malignancy associated with adverse tumor biology. Texture analysis with different imaging modalities has been shown to reflect tumor heterogeneity. The current study analyzed and compared pre-treatment (contrast-enhanced) ceCT and positron emission tomography/computed tomography (PET/CT) tumor heterogeneity using the parameters skewness and kurtosis in patients with primary colorectal cancer with and without liver metastases.
PROCEDURES
The histogram-derived texture parameters skewness and kurtosis were retrospectively analyzed obtained on PET/CT and ceCT images from 50 patients with histopathology proven primary colorectal cancer (32 patients without liver metastases and 18 with liver metastases). All patients underwent pretreatment ceCT and a 2-deoxy-2-[(18)F]Fluoro-D-glucose PET/CT of the whole body for initial staging before treatment. The following parameters were analyzed: (1) skewness ceCT and PET/CT combined, (2) skewness ceCT, (3) skewness PET/CT, (4) kurtosis ceCT and PET/CT combined, (5) kurtosis ceCT, and (6) kurtosis PET/CT. For each parameter, the following comparisons were analyzed: (A) colon tumors in 32 patients without liver metastasis versus colon tumors in 18 patients with liver metastasis, (B) colon tumors (all 50 patients, with and without liver metastases) versus 56 liver metastases of patients with metastatic disease to the liver, (C) colon tumors in 32 patients without liver metastasis versus 56 summed metastasis of the 18 patients with metastatic disease to the liver, and (D) colon tumors in 18 patients with liver metastasis versus summed 56 liver metastasis. Furthermore, ceCT parameters were compared to PET/CT parameters (separately for skewness and kurtosis), and the correlation of the clinical stage with skewness and kurtosis was analyzed.
RESULTS
Skewness and kurtosis were not statistically significantly different in primary colon cancer lesions between patients with or without liver metastases (p > 0.05). However, there were significant differences found between primary colon cancer and hepatic metastases (p < 0.05). Thus, skewness and kurtosis derived by ceCT and PET/CT showed significantly different heterogeneities between primary colon cancer lesions and hepatic metastases. The clinical stage was not associated with skewness or kurtosis (r = 0.06 and r = 0.05).
CONCLUSION
Texture analysis with relatively simple first-order parameters skewness and kurtosis on ceCT and on PET/CT was able to differentiate between primary colon cancer and hepatic metastases. No differentiation was observed between primary colon tumor lesions in patients with or without hepatic metastases. Overall, skewness and kurtosis measured with ceCT and PET/CT seem to have complementary roles in the evaluation of heterogeneity.
Heterogeneity is a key feature of malignancy associated with adverse tumor biology. Texture analysis with different imaging modalities has been shown to reflect tumor heterogeneity. The current study analyzed and compared pre-treatment (contrast-enhanced) ceCT and positron emission tomography/computed tomography (PET/CT) tumor heterogeneity using the parameters skewness and kurtosis in patients with primary colorectal cancer with and without liver metastases.
PROCEDURES
The histogram-derived texture parameters skewness and kurtosis were retrospectively analyzed obtained on PET/CT and ceCT images from 50 patients with histopathology proven primary colorectal cancer (32 patients without liver metastases and 18 with liver metastases). All patients underwent pretreatment ceCT and a 2-deoxy-2-[(18)F]Fluoro-D-glucose PET/CT of the whole body for initial staging before treatment. The following parameters were analyzed: (1) skewness ceCT and PET/CT combined, (2) skewness ceCT, (3) skewness PET/CT, (4) kurtosis ceCT and PET/CT combined, (5) kurtosis ceCT, and (6) kurtosis PET/CT. For each parameter, the following comparisons were analyzed: (A) colon tumors in 32 patients without liver metastasis versus colon tumors in 18 patients with liver metastasis, (B) colon tumors (all 50 patients, with and without liver metastases) versus 56 liver metastases of patients with metastatic disease to the liver, (C) colon tumors in 32 patients without liver metastasis versus 56 summed metastasis of the 18 patients with metastatic disease to the liver, and (D) colon tumors in 18 patients with liver metastasis versus summed 56 liver metastasis. Furthermore, ceCT parameters were compared to PET/CT parameters (separately for skewness and kurtosis), and the correlation of the clinical stage with skewness and kurtosis was analyzed.
RESULTS
Skewness and kurtosis were not statistically significantly different in primary colon cancer lesions between patients with or without liver metastases (p > 0.05). However, there were significant differences found between primary colon cancer and hepatic metastases (p < 0.05). Thus, skewness and kurtosis derived by ceCT and PET/CT showed significantly different heterogeneities between primary colon cancer lesions and hepatic metastases. The clinical stage was not associated with skewness or kurtosis (r = 0.06 and r = 0.05).
CONCLUSION
Texture analysis with relatively simple first-order parameters skewness and kurtosis on ceCT and on PET/CT was able to differentiate between primary colon cancer and hepatic metastases. No differentiation was observed between primary colon tumor lesions in patients with or without hepatic metastases. Overall, skewness and kurtosis measured with ceCT and PET/CT seem to have complementary roles in the evaluation of heterogeneity.
Date Issued
2017-10
Publication Type
Article
Subject(s)
Subjects
Colon cancer
•
Hepatic metastases
•
Kurtosis
•
PET/CT
•
Skewness
•
Texture analysis
•
ceCT
Language(s)
en
Author(s)
Hakami, Yahya Ali | |
Warnock, Geoffrey | |
Fischer, Gabriel | |
Huellner, Martin W | |
Veit-Haibach, Patrick |
Additional Credits
Journal
Molecular imaging and biology
Publisher
Springer
ISSN
1536-1632
Access(Rights)
open.access